Intermixed Dimethyl-Sulfoxide–Based Nonadhesive Liquid Embolic Agents Delivered Serially via the Same Microcatheter for Cerebral AVM Treatment

References

1. 1.↵
   1. Potts MB,
   2. Zumofen DW,
   3. Raz E, et al

   . Curing arteriovenous malformations using embolization. Neurosurg Focus 2014;37:E19 doi:10.3171/2014.6.FOCUS14228 pmid:25175438

   CrossRefPubMed
2. 2.↵
   1. Loh Y,
   2. Duckwiler GR

   ; Onyx Trial Investigators. A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. J Neurosurg 2010;113:733–41 doi:10.3171/2010.3.JNS09370 pmid:20433277

   CrossRefPubMedWeb of Science
3. 3.
   1. Samaniego EA,
   2. Kalousek V,
   3. Abdo G, et al

   . Preliminary experience with Precipitating Hydrophobic Injectable Liquid (PHIL) in treating cerebral AVMs. J Neurointerv Surg 2016;8:1253–55 doi:10.1136/neurintsurg-2015-012210 pmid:26819446

   Abstract/FREE Full Text
4. 4.↵
   1. Akmangit I,
   2. Daglioglu E,
   3. Kaya T, et al

   . Preliminary experience with Squid: a new liquid embolizing agent for AVM, AV fistulas and tumors. Turk Neurosurg 2014;24:565–70 doi:10.5137/1019-5149.JTN.11179-14.0 pmid:25050683

   CrossRefPubMed
5. 5.↵
   1. Pedicelli A,
   2. Lozupone E,
   3. Valente I, et al

   . Pre-operative direct puncture embolization of head and neck hypervascular tumors using SQUID 12. Interv Neuroradiol 2019 Dec 19. [Epub ahead of print] doi:10.1177/1591019919895882 pmid:31856645

   CrossRefPubMed
6. 6.↵
   1. Koçer N,
   2. Hanımoğlu H,
   3. Batur Ş, et al

   . Preliminary experience with precipitating hydrophobic injectable liquid in brain arteriovenous malformations. Diagn Interv Radiology 2016;22:184–89 doi:10.5152/dir.2015.15283 pmid:26782157

   CrossRefPubMed
7. 7.↵
   1. Chapot R,
   2. Stracke P,
   3. Velasco A, et al

   . The pressure-cooker technique for the treatment of brain AVMs. J Neuroradiol 2014;41:87–91 doi:10.1016/j.neurad.2013.10.001 pmid:24405685

   CrossRefPubMed
8. 8.↵
   1. Pasqualin A,
   2. Cioffi F,
   3. Barone G, et al

   . The relevance of anatomic and hemodynamic factors to a classification of cerebral arteriovenous malformations. Neurosurgery 1991;28:370–79 doi:10.1097/00006123-199103000-00006 pmid:2011218

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Davies JM,
   2. Yanamadala V,
   3. Lawton MT

   . Comparative effectiveness of treatments for cerebral arteriovenous malformations: trends in nationwide outcomes from 2000 to 2009. Neurosurg Focus 2012;33:E11 doi:10.3171/2012.5.FOCUS12107 pmid:22746228

   CrossRefPubMed
10. 10.↵
    1. Vaidya S,
    2. Tozer K,
    3. Chen J

    . An overview of embolic agents. Semin Intervent Radiol 2008;25:204–15 doi:10.1055/s-0028-1085930 pmid:21326511

    CrossRefPubMed
11. 11.↵
    1. Brzozowski K,
    2. Ziecina P,
    3. Piasecki P, et al

    . Effectiveness of ONYX liquid embolic agent in endovascular treatment of cerebral arteriovenous malformations - own experience. Eur Congr Radiol 2011
12. 12.↵
    1. Ayad M,
    2. Eskioglu E,
    3. Mericle RA

    . Onyx®: a unique neuroembolic agent. Expert Rev Med Devices 2006;3:705–15 doi:10.1586/17434440.3.6.705 pmid:17280535

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Crowley RW,
    2. Ducruet AF,
    3. McDougall CG, et al

    . Endovascular advances for brain arteriovenous malformations. Neurosurgery 2014;74:S74–82 doi:10.1227/NEU.0000000000000176 pmid:24402496

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Lv X,
    2. Wu Z,
    3. Li Y

    . Arteriovenous malformation in the brain: a theoretical study explaining the behavior of liquid embolic agents during endovascular treatment. Neuroradiol J 2013;26:661–68 doi:10.1177/197140091302600609 pmid:24355185

    CrossRefPubMed
15. 15.↵
    1. Vollherbst DF,
    2. Sommer CM,
    3. Ulfert C, et al

    . Liquid embolic agents for endovascular embolization: evaluation of an established (Onyx) and a novel (PHIL) embolic agent in an in vitro AVM model. AJNR Am J Neuroradiol 2017;38:1377–82 doi:10.3174/ajnr.A5203 pmid:28522669

    Abstract/FREE Full Text
16. 16.↵
    1. Sirakov S,
    2. Sirakov A,
    3. Minkin K, et al

    . Initial experience with the new ethylene vinyl alcohol copolymer based liquid embolic agent Menox in the endovascular treatment of cerebral arteriovenous malformations. J Neurointerv Surg 2019;11:1040–44 doi:10.1136/neurintsurg-2019-014963 pmid:31147436

    Abstract/FREE Full Text
17. 17.↵
    1. Sirakov SS,
    2. Sirakov A,
    3. Minkin K, et al

    . Initial experience with precipitating hydrophobic injectable liquid in cerebral arteriovenous malformations. Interv Neuroradiol 2019;25:58–65 doi:10.1177/1591019918798808 pmid:30223686

    CrossRefPubMed
18. 18.↵
    1. Xu H,
    2. Wang L,
    3. Guan S, et al

    . Embolization of brain arteriovenous malformations with the diluted Onyx technique: initial experience. Neuroradiology 2019;61:471–78 doi:10.1007/s00234-019-02176-2 pmid:30712140

    CrossRefPubMed
19. 19.↵
    1. Gioppo A,
    2. Faragò G,
    3. Caldiera V, et al

    . Medial tentorial dural arteriovenous fistula embolization: single experience with embolic liquid polymer SQUID and review of the literature. World Neurosurg 2017;107:1050.e1–e7 doi:10.1016/j.wneu.2017.08.050 pmid:28826865

    CrossRefPubMed
20. 20.↵
    1. Erbahceci Salik A,
    2. Islim F,
    3. Akgul A, et al

    . Concomitant transarterial and transvenous embolization of a pelvic arteriovenous malformation using a new liquid embolic agent, Squid-12 and detachable coils. Case Rep Vasc Med 2014;2014:972870–75 doi:10.1155/2014/972870 pmid:25180118

    CrossRefPubMed
21. 21.↵
    1. Vollherbst DF,
    2. Otto R,
    3. Hantz M, et al

    . Investigation of a new version of the liquid embolic agent PHIL with extra-low-viscosity in an endovascular embolization model. AJNR Am J Neuroradiol 2018;39:1696–1702 doi:10.3174/ajnr.A5750 pmid:30093480

    Abstract/FREE Full Text
22. 22.↵
    1. Samaniego EA,
    2. Derdeyn CP,
    3. Hayakawa M, et al

    . In vivo evaluation of the new PHIL low viscosity in a swine rete mirabile model. Interv Neuroradiol 2018;24:706–12 doi:10.1177/1591019918784915 pmid:29973081

    CrossRefPubMed
23. 23.↵
    1. Spiotta AM,
    2. James RF,
    3. Lowe SR, et al

    . Balloon-augmented Onyx embolization of cerebral arteriovenous malformations using a dual-lumen balloon: a multicenter experience. J Neurointerv Surg 2015;7:721–27 doi:10.1136/neurintsurg-2014-011285 pmid:25118193

    Abstract/FREE Full Text
24. 24.↵
    1. Jagadeesan BD,
    2. Grigoryan M,
    3. Hassan AE, et al

    . Endovascular balloon-assisted embolization of intracranial and cervical arteriovenous malformations using dual-lumen coaxial balloon microcatheters and Onyx: initial experience. Oper Neurosurg 2013;73:ons238–43 doi:10.1227/NEU.0000000000000186 pmid:24077579

    CrossRefPubMed
25. 25.↵
    1. Vollherbst DF,
    2. Otto R,
    3. Do TD, et al

    . Extra-small dual-lumen micro-balloon catheters can improve endovascular embolization: an experimental in vivo and in vitro study. J Neurointerv Surg 2018;10:1092–96 doi:10.1136/neurintsurg-2018-013752 pmid:29555871

    Abstract/FREE Full Text